Abstract
Mycobacterium bovis is best identified by screening those isolates of the Mycobacterium tuberculosis complex that have any pyrazinamide (PZA) resistance, using a confirmatory test such as spoligotyping, biochemical testing, or genomic deletion analysis. The sensitivity for detection of M. bovis is lowered to 82% when only PZA-monoresistant isolates are screened.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 3530-3532 |
| Number of pages | 3 |
| Journal | Journal of Clinical Microbiology |
| Volume | 43 |
| Issue number | 7 |
| DOIs | |
| State | Published - Jul 2005 |
| Externally published | Yes |
ASJC Scopus subject areas
- Microbiology (medical)
- Microbiology